Steven Cohen Novavax Inc Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novavax Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 218,500 shares of NVAX stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
218,500
Previous 155,000
40.97%
Holding current value
$1.8 Million
Previous $1.96 Million
10.27%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$97.7 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$92 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$63.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$47.8 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $645M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...